Alleviating mitochondrial dysfunction in diabetic cardiomyopathy through the Adipsin and Irak2 pathways[J]. MMR, 2025,12(4):633-635.
Cite this article as: Cummins ML, Delmonte G, Wechsler S, Schlesinger JJ. Alleviating mitochondrial dysfunction in diabetic cardiomyopathy through the Adipsin and Irak2 pathways. Mil Med Res. 2024;11(1):11.
Alleviating mitochondrial dysfunction in diabetic cardiomyopathy through the Adipsin and Irak2 pathways[J]. MMR, 2025,12(4):633-635. DOI: 10.1186/s40779-024-00513-y.
Cite this article as: Cummins ML, Delmonte G, Wechsler S, Schlesinger JJ. Alleviating mitochondrial dysfunction in diabetic cardiomyopathy through the Adipsin and Irak2 pathways. Mil Med Res. 2024;11(1):11. DOI: 10.1186/s40779-024-00513-y.
Alleviating mitochondrial dysfunction in diabetic cardiomyopathy through the Adipsin and Irak2 pathways
Adipsin inhibits Irak2 mitochondrial translocation and improves fatty acid β-oxidation to alleviate diabetic cardiomyopathy
Interleukin-1 receptor associated kinase 2 is a functional downstream regulator of complement factor D that controls mitochondrial fitness in diabetic cardiomyopathy
Better therapy for combat injury
地铁运行荷载引起的隧道地基土动力响应分析
开裂预应力混凝土梁的检测、评估和加固
相关作者
Yang Cao
Dong-Dong Sun
Xuan Zhang
Xiao-Ming Gu
Cong-Ye Li
Xiao Zhang
Hao Wang
Lei Xin
相关机构
Department of Cardiology, Xijing Hospital, Air Force Medical University
Department of Basic Medicine, Air Force Medical University
Department of Physiology and Pathophysiology, Air Force Medical University
Institute for Hospital Management Research, Chinese PLA General Hospital
Department of Medicine, Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Einstein Institute for Aging Research, Albert Einstein College of Medicine